Vimarsana
Biggest News Aggregation in the World

Page 15 - Package Leaflet News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Package Leaflet. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Package Leaflet Today - Breaking & Trending Today

Moderna, Inc.: Moderna Announces European Medicines Agency Authorizes Third Dose of COVID-19 Vaccine for Immunocompromised Individuals Aged 12 Years and Older - Vimarsana News

Moderna, Inc.: Moderna Announces European Medicines Agency Authorizes Third Dose of COVID-19 Vaccine for Immunocompromised Individuals Aged 12 Years and Older

Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines today announced that the European Medicines Agency (EMA) has authorized a third dose

Pfizer and BioNTech Receive First Authorization in European - Vimarsana News

Pfizer and BioNTech Receive First Authorization in European

BioNTech SE (Nasdaq: BNTX) today announced that the Conditional Marketing Authorization (CMA) for COMIRNATY ® in the European Union (EU) has been expanded to include individuals 12 to 15 years of age. This follows the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) positive opinion to authorize the vaccine in this age group. The extended indication for the CMA for COMIRNATY ® is valid in all 27 EU member states. COMIRNATY ® was the first COVID-19 vaccine to receive authorization in the EU and is the first to have its CMA extended to adolescents. Di...

BioNTech SE: Pfizer and BioNTech Receive First Authorization in European Union for COVID-19 Vaccine in Adolescents - Vimarsana News

BioNTech SE: Pfizer and BioNTech Receive First Authorization in European Union for COVID-19 Vaccine in Adolescents

NEW YORK and MAINZ, GERMANY, May 28, 2021 - Pfizer Inc.(Nasdaq: BNTX) today announced that the Conditional Marketing Authorization (CMA) for COMIRNATY in the European Union (EU) has been expanded to include

Investegate |BioNTech SE Announcements | BioNTech SE: Pfizer and BioNTech Receive First Authorization in European Union for COVID-19 Vaccine in Adolescents - Vimarsana News

Investegate |BioNTech SE Announcements | BioNTech SE: Pfizer and BioNTech Receive First Authorization in European Union for COVID-19 Vaccine in Adolescents

Investegate announcements from BioNTech SE, Pfizer and BioNTech Receive First Authorization in European Union for COVID-19 Vaccine in Adolescents

BioNTech SE: Pfizer and BioNTech to Supply the European Union with up to 1.8 Billion Additional Doses of COMIRNATY - Vimarsana News

BioNTech SE: Pfizer and BioNTech to Supply the European Union with up to 1.8 Billion Additional Doses of COMIRNATY

New agreement to supply 900 million doses to the European Commission (EC), with option to request up to an additional 900 million dosesAdditional dose deliveries beginning December 2021 through 2023Pfizer